PUMA Welcomes AC Milan Star Theo Hernández to the Family 
McDonald's China Faces Backlash for Food Hygiene Violations 
Converse Faces Job Cuts as Nike Aims for $2 Billion in Cost Savings 
How supermarkets are changing their branding to make you think they’re cheaper 
Burger King’s Largest Franchisee Carrols, Acquired by RBI for $1 Billion, $500M Revamp 
From Burger King to McDonald’s: Fast-Food Prices Surge Dramatically in Recent Years 
McDonald’s Rolls Out $5 Meal Deals to Emphasize Affordability Amid Rising Costs 
Shein's Potential London IPO Could Revitalize LSE Amid Geopolitical Tensions 
Cancer drug pollution is a growing global concern 
Skepta and PUMA Launch Groundbreaking Collection 
Skechers Sales Surge as Growth Lags for Nike and Adidas; Nike Eyes 2024 Olympics 
The 2023 Sir Paul Curran award for academic journalism goes to Barbara Sahakian 
ECB Calls for Monitoring and Possible Regulation of AI in Finance 
Semaglutide's Benefits Beyond Weight Loss: New Insights from the SELECT Trial 
BURLINGTON, Mass., April 07, 2016 -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Michael Clayman, M.D., President and Chief Executive Officer, will provide a company overview at the 15th Annual Needham Healthcare Conference on Wednesday, April 13, 2016 at 3:40 p.m. EDT in New York, NY.
To access the live webcast and subsequent archived recordings for the presentation, please visit the Flexion website at http://flexiontherapeutics.com/.
About Flexion Therapeutics
Flexion is a specialty pharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with OA. The company's lead product candidate, Zilretta, is being investigated for its potential to provide improved analgesic therapy for the millions of U.S. patients who receive IA injections for knee OA annually. The company is also investigating another product candidate, FX007, a locally administered TrkA receptor antagonist for post-operative pain.
Investor Contact David Carey Lazar Partners LTD T: 212-867-1768 [email protected] Media Contact Mariann Caprino TogoRun T : 917.242.1087 [email protected] Corporate Contact Fred Driscoll Chief Financial Officer Flexion Therapeutics, Inc. T: 781-305-7763 [email protected]
